Ceramide Activated Protein Phosphatases

神经酰胺激活蛋白磷酸酶

基本信息

项目摘要

Ceramide constitutes a family of closely related molecules that function as bioeffector lipids with roles in the regulation of stress responses and growth/death of various human cancer cells. Critical missing elements in our understanding of ceramide stem from the lack of defining compartment-specific functions of ceramides and from lack of molecularly- defined targets of action. Studies in our lab supported by this project have identified ceramide-activated Ser–Thr phosphatases (CAPPs), specifically PP1 and PP2A as direct targets activated by ceramide in vitro. Recent results have provided us a breakthrough in defining a specific pathway of ceramide generation at the plasma membrane (PM). Here, we will investigate the hypothesis that ceramide generated at the PM acutely activates PP1α that leads to the dephosphorylation of distinct proteins, launching a distinct program of regulation of cell adhesion and migration. We are also developing a novel assay to quantitate PM ceramide specifically. With this breakthrough, we will address these aims: Aim 1. Develop a quantitative assay to measure ceramide generation at the PM and define key enzymes of ceramide metabolism in this compartment (steady state). Aim 2. Define stimulus-induced formation of PM ceramide and the mechanisms involved. Aim 3. Define biochemical mechanisms of regulation of PP1a by PM ceramide. Taken together, these approaches should result, for the first time, in clearly defining a specific, direct, and relevant target for ceramide action (PP1) with a specific function in mediating the effects of PM ceramide on cell adhesion and migration.
神经酰胺是一类密切相关的生物效应分子

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ACSL1 is a key regulator of inflammatory and macrophage foaming induced by short-term palmitate exposure or acute high-fat feeding.
  • DOI:
    10.1016/j.isci.2023.107145
  • 发表时间:
    2023-07-21
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Al-Rashed, Fatema;Haddad, Dania;Al Madhoun, Ashraf;Sindhu, Sardar;Jacob, Texy;Kochumon, Shihab;Obeid, Lina M.;Al-Mulla, Fahd;Hannun, Yusuf A.;Ahmad, Rasheed
  • 通讯作者:
    Ahmad, Rasheed
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YUSUF AWNI HANNUN其他文献

YUSUF AWNI HANNUN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YUSUF AWNI HANNUN', 18)}}的其他基金

Protein kinase C in Lung Cancer with mutant EGFR
EGFR 突变肺癌中的蛋白激酶 C
  • 批准号:
    10618917
  • 财政年份:
    2020
  • 资助金额:
    $ 39.54万
  • 项目类别:
Protein kinase C in Lung Cancer with mutant EGFR
EGFR 突变肺癌中的蛋白激酶 C
  • 批准号:
    10454776
  • 财政年份:
    2020
  • 资助金额:
    $ 39.54万
  • 项目类别:
Protein kinase C in Lung Cancer with mutant EGFR
EGFR 突变肺癌中的蛋白激酶 C
  • 批准号:
    9888660
  • 财政年份:
    2020
  • 资助金额:
    $ 39.54万
  • 项目类别:
Ceramide Activated Protein Phosphatases
神经酰胺激活蛋白磷酸酶
  • 批准号:
    10208802
  • 财政年份:
    2018
  • 资助金额:
    $ 39.54万
  • 项目类别:
Ceramide Activated Protein Phosphatases
神经酰胺激活蛋白磷酸酶
  • 批准号:
    10434893
  • 财政年份:
    2018
  • 资助金额:
    $ 39.54万
  • 项目类别:
Neutral Sphingomyelinases and Bioactive Ceramides
中性鞘磷脂酶和生物活性神经酰胺
  • 批准号:
    10437811
  • 财政年份:
    2016
  • 资助金额:
    $ 39.54万
  • 项目类别:
Neutral Sphingomyelinases and Bioactive Ceramides
中性鞘磷脂酶和生物活性神经酰胺
  • 批准号:
    10640899
  • 财政年份:
    2016
  • 资助金额:
    $ 39.54万
  • 项目类别:
Neutral sphingomyelinases and bioactive ceramides
中性鞘磷脂酶和生物活性神经酰胺
  • 批准号:
    9071506
  • 财政年份:
    2016
  • 资助金额:
    $ 39.54万
  • 项目类别:
Diversity Supplement for Bernandie Jean: Neutral sphingomyelinases and bioactive ceramides
Bernandie Jean 的多样性补充:中性鞘磷脂酶和生物活性神经酰胺
  • 批准号:
    9752140
  • 财政年份:
    2016
  • 资助金额:
    $ 39.54万
  • 项目类别:
Admin Supplement: Neutral Sphingomyelinases and Bioactive Ceramides
管理补充剂:中性鞘磷脂酶和生物活性神经酰胺
  • 批准号:
    10797322
  • 财政年份:
    2016
  • 资助金额:
    $ 39.54万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.54万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了